For instance, this has been demonstrated in a genetic alpha‐synuclein‐related model of PD, in which the application of the PDE5 inhibitor zaprinast fully restored aberrant long‐term depression to normal conditions via the stimulation of a cGMP‐PKG‐dependent intracellular signaling pathway.22 Here, PDE5A is linked to Parkinson disease.